RHINOGARD BOVINE HERPESVIRUS 1 LIVE INTRANASAL VACCINE FOR CATTLE

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Active ingredient:

BOVINE HERPESVIRUS 1

Available from:

ZOETIS AUSTRALIA PTY LTD

INN (International Name):

bovine rhinotracheitis

Pharmaceutical form:

MISC. AURAL, OPHTHALMIC, ORO/NASO PHARYNGEAL

Composition:

BOVINE HERPESVIRUS 1 VACCINE-VIRAL Active 0.0 P

Units in package:

1 x 10 dose vial; 1 x 50 dose vial; 10 x 10 dose vial; 10 x 50 dose vial; 5 x 10 dose vial; 5 x 50 dose vial

Class:

VM - Veterinary Medicine

Manufactured by:

ZOETIS AUSTRALIA

Therapeutic group:

CATTLE - FEEDLOT | BEEF | BOVINE | DAIRY COW

Therapeutic area:

IMMUNOTHERAPY

Therapeutic indications:

BOVINE HERPESVIRUS | VACCINE | EQUINE ROTAVIRUS

Product summary:

Poison schedule: 0; Withholding period: MEAT: Zero (0) days. ESI: Zero (0) days If cattle are destined for live export , advice should be sought on the use of Rhinogard Bovine Herpesvirus 1 Live Intr anasal Vaccine for Cattle from the expor ter, a veterinarian or Zoetis Australia Pty Ltd on 1800 814 883 before administe ring the vaccine to ensure the cattle wi ll meet the pre-export testing protocols for IBR of the destination market.; Host/pest details: CATTLE - FEEDLOT: [BOVINE HERPESVIRUS, VACCINE]; Poison schedule: 4; Withholding period: MEAT: Zero (0) days. ESI: Zero (0) days If cattle are destined for live export , advice should be sought on the use of Rhinogard Bovine Herpesvirus 1 Live Intr anasal Vaccine for Cattle from the expor ter, a veterinarian or Zoetis Australia Pty Ltd on 1800 814 883 before administe ring the vaccine to ensure the cattle wi ll meet the pre-export testing protocols for IBR of the destination market.; Host/pest details: CATTLE - FEEDLOT: [BOVINE HERPESVIRUS, VACCINE]; Poison schedule: 4; Withholding period: MEAT: Zero (0) days. (ESI): Zero (0) da ys.; Host/pest details: CATTLE - FEEDLOT: [BOVINE HERPESVIRUS, VACCINE]; Poison schedule: 4; Withholding period: WHP:14 DAYS.; Host/pest details: CATTLE - FEEDLOT: [BOVINE HERPESVIRUS, VACCINE]; Poison schedule: 4; Withholding period: ; Host/pest details: CATTLE - FEEDLOT: [BOVINE HERPESVIRUS, VACCINE]; Aids in the control of bovine herpes virus 1 infection in feedlot cattle. Assists in preventing loss of weight gain and loss of feed conversion due to herpes virus 1 infection in feedlot cattle.

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

RHINOGARD BOVINE HERPESVIRUS 1 LIVE INTRANASAL VACCINE FOR CATTLE
49679/137341
Product Name:
APVMA Approval No:
Label Name:
RHINOGARD BOVINE HERPESVIRUS 1 LIVE INTRANASAL VACCINE FOR CATTLE
Signal Headings:
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
Contains ≥ 10^ 4 CCID50/dose (2 mL) BHV1
Claims:
Aids in the control of bovine herpesvirus 1 infection in cattle.
Assists in preventing loss of weight gain and loss of feed conversion
due to bovine
herpesvirus 1 infection in cattle.
Net Contents:
1, 5 and 10 x 10 dose vial
1, 5 and 10 x 50 dose vial
Directions for Use:
Restraints:
Contraindications:
Precautions:
This product has not been tested in breeding or lactating cattle.
Side Effects:
Nasal discharge and/or fever may be present in cattle for up to one
week after vaccination.
Dosage and
Administration:
USE RECONSTITUTED PRODUCT WITHIN 8 HOURS OF MIXING.
For Intranasal Use Only
2 mL dose per animal by intranasal vaccination.
Preparation of the vaccine: RLP APPROVED
KEEP THE VACCINE AND SALINE PACK cool and out of direct sunlight.
For the 10 dose and the 50 dose presentation, a 100 mL pack of saline
is required.
For the 10 dose pack:
1. Using a sterile needle and syringe, draw up 20 mL of sterile
saline.
2. Add to the freeze dried vaccine in the vial to reconstitute the
freeze dried pellet. Once
added, swirl gently, do not shake to dissolve.
3. The glass vial now contains 10 x 2 mL doses of vaccine.
For the 50 dose pack:
1. Using a sterile needle and syringe, draw up 20 mL of sterile
saline.
2. Add to the freeze dried vaccine in the vial to reconstitute the
freeze dried pellet.
Once added, swirl gently, do not shake to dissolve. Draw up the
reconstituted vaccine into
the syringe and transfer it to the saline pack.
3. Repeat the above two points, using the same saline pack, to double
rinse the glass
vaccine vial to remove all vaccine and transfer into the saline pack.
4. Gently invert the saline pack several times to evenly mix the
contents.
5. The 100 mL saline pack now contains 50 x 2 mL doses of vaccine.

Summary of Product characteristics

PRODUCT NAME: RHINOGARD
PAGE: 1 OF 4
THIS REVISION ISSUED: SEPTEMBER, 2011
MATERIAL SAFETY DATA SHEET
Issued by: Pfizer Australia Pty Ltd
Phone: [phone]
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800
764 766 IN NEW ZEALAND)
SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER
Pfizer Australia Pty Ltd
38-42 Wharf Road
West Ryde NSW 2114
Tel: [phone]
Fax: [phone]
____________________________________
PFIZER AUSTRALIA PTY LTD
A.B.N. 50 008 422 348
CHEMICAL NATURE:
Water solution and suspension of ingredients.
TRADE NAME:
RHINOGARD
PRODUCT USE:
Intranasal vaccine for the control of bovine herpes virus 1 infection
in cattle. Assists in
preventing loss of weight gain and loss of feed conversion due to
bovine herpes virus
1 infection in feedlot cattle.
CREATION DATE:
AUGUST, 2011
THIS VERSION ISSUED:
SEPTEMBER, 2011
and is valid for 5 years from this date.
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S23. Do not breathe mists.
SUSMP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
E
E
E
M
M
M
E
E
E
R
R
R
G
G
G
E
E
E
N
N
N
C
C
C
Y
Y
Y
O
O
O
V
V
V
E
E
E
R
R
R
V
V
V
I
I
I
E
E
E
W
W
W
PHYSICAL DESCRIPTION & COLOUR
: Clear pink to yellow liquid.
ODOUR:
No odour.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product.
P
P
P
O
O
O
T
T
T
E
E
E
N
N
N
T
T
T
I
I
I
A
A
A
L
L
L
H
H
H
E
E
E
A
A
A
L
L
L
T
T
T
H
H
H
E
E
E
F
F
F
F
F
F
E
E
E
C
C
C
T
T
T
S
S
S
INHALATION:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. In addition
product is unlikely to
cause any discomfort or irritation.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN CONTACT:
SHORT TERM EXPOSURE:
Available